Priorities for developing respiratory syncytial virus vaccines in different target populations

See allHide authors and affiliations

Science Translational Medicine  18 Mar 2020:
Vol. 12, Issue 535, eaax2466
DOI: 10.1126/scitranslmed.aax2466

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article